Skip to main content
search

March 26, 2025

We’re thrilled to introduce the launch of our revamped website and refreshed brand—welcome to the new Certara.com! This is more than a simple visual update; it’s a refreshed representation of who we are, what we do, and how we partner with our customers to revolutionize drug development. At Certara, we’ve always strived to find a better way to bring life-changing medicines to market—replacing complexity with clarity, guesswork with data-driven insights, and uncertainty with confidence. Our new site is designed to highlight how Certara supports customers through every stage of the drug development lifecycle, from molecule to market.

A simpler, smarter way to navigate Certara expertise

Our new solutions pages offer a seamless, intuitive way to discover Certara’s integrated offerings across critical phases of development: Discovery, Preclinical, Early Clinical, Late Clinical, Market Access & Commercial. Solutions for Regulatory and strategic leadership are also showcased. Whether it’s leveraging AI-enabled cheminformatics to accelerate discovery, applying biosimulation to optimize early trials, or streamlining regulatory approvals, our refreshed structure mirrors how our customers think and work—making it easier than ever to find solutions tailored to your needs.

A resource hub showcasing the latest advancements in Model Informed Drug Development

We’ve also expanded our Resources section to serve as a dynamic hub for the latest advancements in drug development. From scientific publications to webinars and customer success stories, our Learning Center demonstrates how our unrivaled science, technology, and talent power innovation. This space reflects the global impact of our work, showcasing how we’re advancing science, improving lives, and driving business success across the life sciences industry.

“One Certara”, unified for your success

This launch is more than a website—it’s a reflection of our unified approach to support you at every step of your drug development journey. At Certara, we integrate science, advanced modeling, and regulatory expertise into a powerful partnership to help you tackle even the most complex challenges. “Transforming Drug Development for Good” isn’t just a tagline—it’s our commitment to delivering solutions that save time, empower decision-making, and ultimately improve patient outcomes. That’s the promise of “One Certara”.

Driven by people, fueled by purpose

A brand is only as strong as the people behind it. This incredible transformation was brought to life by the talent, creativity, and collaboration of the entire Certara team, especially the marketing team who led the charge. Their vision, attention to detail, and commitment to our mission ensured every page, message, and interaction reflects who we are and the value we bring to our customers.

While we celebrate this milestone, we’re even more excited about the future ahead. Explore the new Certara.com and discover how we can partner to transform drug development—together. We’d love to hear your feedback about our new site and refreshed brand. Feel free to reach out to us to share your thoughts!

Sheila Rocchio

Chief Marketing Officer

Sheila Rocchio is the Chief marketing Officer at Certara where she leads the global marketing function. She has more than 20 years of experience in marketing, product management and strategy roles in life sciences technology and services companies. Her most recent role was Chief Marketing Officer at eClinical Solutions where she managed all aspects of marketing including branding, communications, lead generation, and product marketing. Prior to joining eClinical Solutions, she held marketing and executive leadership roles at PHT Corporation where she was a driving force in commercializing and accelerating the industry adoption of innovative clinical technology.

Ms. Rocchio’s industry honors include being selected for the PharmaVOICE 100 most influential people in life sciences and as the Massachusetts Technology Leadership Council Emerging Executive of the Year. She holds a BS from MIT and an MBA from Boston College.